Ipsen S.A. (IPSEY)
Develops specialty medicines for cancer, rare diseases, and neurological disorders.
$46.70+0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+44.9%
The outlook
IPSEY trades at $46.70, positioned well above both its 50- and 200-day moving averages and sitting near the upper end of its 52-week range. The stock carries a trailing P/E of 30.9, reflecting a premium valuation. Analyst sentiment skews constructive based on available coverage.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range79% of the way from its 52-week low to high
Market cap
$15.44B
52-wk high
$51.10
52-wk low
$30.05
50-day avg
$46.19
200-day avg
$42.33
Trailing P/E
30.9